Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coartem Dispersible vs Crushed Tablet in Children with Malaria
NCT00386763Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, single-blind trial of lumefantrine in Plasmodium falciparum malaria (2 arms), sponsored by Novartis. Primary endpoint: Proportion of patients free of parasites at day 28. Started Aug 2006; status: completed.
02
Drugs
lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00386763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386763.